PMN
Income statement / Annual
Last year (2024), ProMIS Neurosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, ProMIS Neurosciences, Inc.'s net income was $2.78 M.
See ProMIS Neurosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$8.14 K |
$1.57 K |
$1.20 K |
$348.74 |
$7.87 K |
$2.00 K |
$14.37 K |
| Cost of Revenue |
$0.00
|
$10.44 M
|
$0.00
|
$5.85 M
|
$3.18 M
|
$4.74 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$10.44 M
|
$0.00
|
-$5.84 M
|
-$3.18 M
|
-$4.73 M
|
$348.74
|
$7.87 K
|
$2.00 K
|
$14.37 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
-717.97
|
-2032.96
|
-3938.53
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$10.64 M
|
$7.88 M
|
$16.09 M
|
$4.95 M
|
$3.18 M
|
$4.74 M
|
$5.44 M
|
$3.15 M
|
$1.39 M
|
$763.96 K
|
| General & Administrative Expenses |
$6.19 M
|
$7.39 M
|
$7.29 M
|
$3.31 M
|
$2.44 M
|
$2.62 M
|
$2.02 M
|
$1.64 M
|
$1.17 M
|
$682.26 K
|
| Selling & Marketing Expenses |
$0.00
|
-$1.01 M
|
$0.00
|
$0.00
|
$36.48 K
|
$43.89 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.19 M
|
$6.38 M
|
$7.29 M
|
$3.31 M
|
$2.48 M
|
$2.66 M
|
$2.02 M
|
$1.64 M
|
$1.17 M
|
$682.26 K
|
| Other Expenses |
$0.00
|
-$5.81 M
|
$0.00
|
$0.00
|
-$3.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$16.83 M
|
$8.45 M
|
$23.38 M
|
$8.26 M
|
$2.48 M
|
$7.40 M
|
$7.46 M
|
$4.79 M
|
$2.56 M
|
$1.45 M
|
| Cost And Expenses |
$16.83 M
|
$18.90 M
|
$23.38 M
|
$8.26 M
|
$5.66 M
|
$12.13 M
|
$7.46 M
|
$4.79 M
|
$2.56 M
|
$1.45 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$4.73 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$76.78 K
|
$201.39 K
|
$282.06 K
|
$416.29 K
|
$0.00
|
$0.00
|
$0.00
|
$5.65 K
|
$15.89 K
|
$23.98 K
|
| Depreciation & Amortization |
$0.00
|
$28.04 K
|
$11.22 K
|
$45.83 K
|
$15.73 K
|
$8.56 K
|
$4.90 K
|
$5.31 K
|
$4.96 K
|
$5.50 K
|
| EBITDA |
$2.86 M |
-$17.81 M |
-$17.77 M |
-$9.33 M |
-$5.65 M |
-$7.39 M |
-$7.46 M |
-$4.78 M |
-$2.55 M |
-$1.51 M |
| EBITDA Ratio |
0
|
0
|
0
|
-1146.13
|
-3608.23
|
-6146.17
|
-21390.27
|
-606.99
|
-1275.52
|
-104.81
|
| Operating Income Ratio |
0
|
0
|
0
|
-1013.64
|
-3618.14
|
-10092.83
|
-21404.32
|
-607.67
|
-1278
|
-105.19
|
| Total Other Income/Expenses Net |
$19.61 M
|
$1.39 M
|
$5.32 M
|
-$1.50 M
|
$0.00
|
$4.74 M
|
$0.00
|
-$5.65 K
|
-$11.82 K
|
-$17.28 K
|
| Income Before Tax |
$2.78 M
|
-$17.51 M
|
-$18.06 M
|
-$9.24 M
|
-$5.66 M
|
-$7.40 M
|
-$7.46 M
|
-$4.79 M
|
-$2.57 M
|
-$1.53 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
-1135.63
|
-3618.14
|
-6153.29
|
-21404.32
|
-608.39
|
-1283.9
|
-106.4
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$415.03 K
|
$0.00
|
$0.00
|
$0.00
|
$5.65 K
|
$11.82 K
|
$0.00
|
| Net Income |
$2.78 M
|
-$17.51 M
|
-$18.06 M
|
-$9.66 M
|
-$5.66 M
|
-$7.40 M
|
-$7.46 M
|
-$4.79 M
|
-$2.57 M
|
-$1.53 M
|
| Net Income Ratio |
0
|
0
|
0
|
-1186.62
|
-3618.14
|
-6153.29
|
-21404.32
|
-608.39
|
-1283.9
|
-106.4
|
| EPS |
2.75 |
-35.5 |
-42.5 |
-41.75 |
-23.25 |
-32.75 |
-46.75 |
-35 |
-22.75 |
-21.25 |
| EPS Diluted |
2.75 |
-35.5 |
-42.5 |
-41.75 |
-23.25 |
-32.75 |
-46.75 |
-35 |
-22.75 |
-21.25 |
| Weighted Average Shares Out |
$1.04 M
|
$491.71 K
|
$300.10 K
|
$231.42 K
|
$190.40 K
|
$173.20 K
|
$159.46 K
|
$137.19 K
|
$113.26 K
|
$71.98 K
|
| Weighted Average Shares Out Diluted |
$1.06 M
|
$491.71 K
|
$300.10 K
|
$231.43 K
|
$190.40 K
|
$173.20 K
|
$159.46 K
|
$137.19 K
|
$113.26 K
|
$71.98 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
